Chemists at Otto von Guericke University Magdeburg have synthesized key molecular components of Neosorangicin A, a naturally occurring compound with potential to address antibiotic resistance. Professor Dieter Schinzer's team achieved this breakthrough using relay synthesis, a multi-step chemical technique that builds complex molecules through sequential reactions.
Neosorangicin A represents a reserve antibiotic candidate. Reserve antibiotics are drugs held in reserve specifically for resistant bacterial infections when standard treatments fail. The compound's natural origin suggests it may possess activity against pathogens resistant to conventional antibiotics.
The research addresses a critical public health problem. Antibiotic resistance develops when bacteria evolve mechanisms to survive drug treatment, rendering previously effective medications useless. The World Health Organization identifies this as a top global threat. New antibiotic options remain scarce because pharmaceutical development is costly and time-consuming, making natural product leads valuable.
Relay synthesis differs from traditional chemical routes. Rather than attempting to build the entire molecule in one pathway, relay synthesis breaks construction into manageable segments. Chemists synthesize smaller pieces independently, then strategically combine them. This modular approach reduces steps in some syntheses and can improve efficiency and yield.
Schinzer's team's achievement removes a major barrier to Neosorangicin A development. Extracting sufficient quantities of the antibiotic from its natural source would be impractical for drug development. Laboratory synthesis enables researchers to produce adequate supplies for testing, modification, and potential clinical trials. The ability to synthesize building blocks also allows chemists to create structural variants, exploring which molecular features drive antimicrobial activity.
The work represents early-stage research. Demonstrating that key building blocks can be synthesized does not guarantee Neosorangicin A will become an effective antibiotic. Researchers must still complete total synthesis